PYCR1 and lung cancer: Functional studies in PYCR1-knockout (PYCR1-KO) lung cancer cells generated via CRISPR–Cas9 showed reduced cell proliferation, migration, colony formation and tumor spheroid growth both in vitro and in vivo.